August 28, 2014
Have you registered yet? Don’t miss the latest on cure research and HIV eradication on AVAC’s upcoming webinar—State of the Art HIV Cure: Where are we now and where are we going?
. The webinar features one of the leaders in the field and AIDS 2014 plenary speaker, Jintanat Ananworanich, from the US Military HIV Research Program and Thai Red Cross AIDS Research Center.
Join us this Wednesday, September 3 at 10am ET (visit www.timeanddate.com
for the time in your area). Register here.
Whether or not you were able to attend AIDS 2014 in Melbourne
, you probably have questions about what happened—and what it all meant. As part of our Research & Reality
series, AVAC has organized a webinar series focused on issues raised at AIDS 2014 that will give you a chance to ask these questions—and more.
Check out the full schedule below and please join us next week for the first one
State of the Art HIV Cure: Where are we now and where are we going?
The field of cure research is evolving and expanding, with various proposed trials that require informed engagement from many stakeholders. Get an update, discuss research and have your questions answered by plenary speaker Jintanat Ananworanich from the US Military HIV Research Program.
September 3, 10–11am ET; register here
UNAIDS, Targets and Civil Society
In Melbourne, UNAIDS launched a new initiative known as “90-90-90”, which lays out new targets for testing, treatment and virologic suppression. Where did these targets come from, what do they mean—and where does prevention fit in? Chris Collins, Chief of the Community Mobilization Division at UNAIDS, will address these questions and more.
Time and date to be determined; update available here shortly
Latest developments in VMMC research and implementation
AIDS 2014 brought more updates on voluntary medical male circumcision (VMMC) including new data on risk behaviors in circumcised men, the impact of cash transfers as part of VMMC programming and more. Kenyan researcher and implementer Kawango Agot will review the latest findings.
September 17, 10–11am ET; register here
Results of the iPrEx open-label extension (iPrEx OLE): PrEP uptake, sexual practices and HIV incidence
Get details on the iPrEx OLE study from principal investigator Robert Grant, who presented the data at AIDS 2014. The first open-label PrEP study to publish results, data from iPrEx OLE begin to answer a number of questions on PrEP use in the “real world”.
September 24, 10–11am ET; register here
Data and Uncertainty: Understanding updates on hormonal contraceptives and HIV
AIDS 2014 featured analyses of data on the potential relationship between hormonal contraceptives and risk of HIV infection. Researchers Charles Morrison (FHI 360), Kristin Wall (Emory University) and Mary Lyn Gaffield (WHO) will discuss the newest findings and guidance.
October 1, 10–11am ET; register here
As always, questions or comments are most welcome
, and we look forward to welcoming you on the webinars!